Found: 33
Select item for more details and to access through your institution.
An international survey to inform priorities for new guidelines on von Willebrand disease.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 106, doi. 10.1111/hae.13881
- By:
- Publication type:
- Article
Chromic phosphate‐32 colloid radiosynovectomy for the treatment of haemophilic synovitis: A long‐term follow‐up study.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 136, doi. 10.1111/hae.13879
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 1, doi. 10.1111/hae.13788
- Publication type:
- Article
Rhenium‐188 radiosynovectomy for chronic haemophilic synovitis: Evaluation of its safety and efficacy in haemophilic patients.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 142, doi. 10.1111/hae.13880
- By:
- Publication type:
- Article
Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 6, doi. 10.1111/hae.13907
- By:
- Publication type:
- Article
Measuring the impact of changing from standard half‐life (SHL) to extended half‐life (EHL) FVIII prophylaxis on health‐related quality of life (HRQoL) in boys with moderate/severe haemophilia A: Lessons learned with the CHO‐KLAT tool
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 73, doi. 10.1111/hae.13905
- By:
- Publication type:
- Article
Laboratory coagulation tests and emicizumab treatment A United Kingdom Haemophilia Centre Doctors' Organisation guideline.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 151, doi. 10.1111/hae.13903
- By:
- Publication type:
- Article
von Willebrand Disease and other hereditary haemostatic factor deficiencies in women with a history of postpartum haemorrhage.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 97, doi. 10.1111/hae.13900
- By:
- Publication type:
- Article
Inhibitor epidemiology and genetic‐related risk factors in people with haemophilia from Côte d'Ivoire.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 79, doi. 10.1111/hae.13902
- By:
- Publication type:
- Article
Evaluation of pre‐analytic heat treatment protocol used in the CDC Nijmegen‐Bethesda assay for heat inactivation of extended half‐life haemophilia treatment products.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e28, doi. 10.1111/hae.13901
- By:
- Publication type:
- Article
Rotational thromboelastometry can predict the probability of bleeding events in a translational rat model of haemophilia A following gene‐based FVIIa prophylaxis.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 164, doi. 10.1111/hae.13899
- By:
- Publication type:
- Article
An overview of turoctocog alfa pegol (N8‐GP; ESPEROCT<sup>®</sup>) assay performance: Implications for postadministration monitoring.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 156, doi. 10.1111/hae.13897
- By:
- Publication type:
- Article
A rare case of Glanzmann's thrombasthenia and factor VII deficiency due to a combination of pathogenic and non‐pathogenic gene variants.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e26, doi. 10.1111/hae.13898
- By:
- Publication type:
- Article
Excessive breakthrough bleeding in haemophilia B patients on factor IX‐albumin fusion protein prophylactic therapy: A single centre case series.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e23, doi. 10.1111/hae.13896
- By:
- Publication type:
- Article
Can we compare haemophilia carriers with clotting factor deficiency to male patients with mild haemophilia?
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 117, doi. 10.1111/hae.13891
- By:
- Publication type:
- Article
Novel treatment of combined factor V and factor VIII deficiency with Factor Eight Inhibitor Bypass Activity.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e21, doi. 10.1111/hae.13895
- By:
- Publication type:
- Article
Prophylactic vs episodic treatment to prevent bleeds and preserve joint function in Thai children with moderate and severe haemophilia A.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e18, doi. 10.1111/hae.13894
- By:
- Publication type:
- Article
Bleeding assessment in haemophilia carriers—High rates of bleeding after surgical abortion and intrauterine device placement: A multicentre study in China.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 122, doi. 10.1111/hae.13889
- By:
- Publication type:
- Article
Clinical application of Web Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS‐Hemo): Patterns of blood sampling and patient characteristics among clinician users.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 56, doi. 10.1111/hae.13882
- By:
- Publication type:
- Article
Maternal and neonatal outcomes in carriers of haemophilia A and B: A Swedish Medical Birth Register study.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e14, doi. 10.1111/hae.13884
- By:
- Publication type:
- Article
Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 64, doi. 10.1111/hae.13883
- By:
- Publication type:
- Article
Achieving the unimaginable: Health equity in haemophilia.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 17, doi. 10.1111/hae.13862
- By:
- Publication type:
- Article
Age‐related severity and distribution of haemophilic arthropathy of the knee, ankle and elbow among Chinese patients with haemophilia.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 129, doi. 10.1111/hae.13858
- By:
- Publication type:
- Article
Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 41, doi. 10.1111/hae.13877
- By:
- Publication type:
- Article
SHP656, a polysialylated recombinant factor VIII (PSA‐rFVIII): First‐in‐human study evaluating safety, tolerability and pharmacokinetics in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 47, doi. 10.1111/hae.13878
- By:
- Publication type:
- Article
Fibrinogen concentrates in hereditary fibrinogen disorders: Past, present and future.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 25, doi. 10.1111/hae.13876
- By:
- Publication type:
- Article
PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e11, doi. 10.1111/hae.13875
- By:
- Publication type:
- Article
Sleeve gastrectomy in haemophilia type A: Reducing the costs of prophylaxis.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e9, doi. 10.1111/hae.13872
- By:
- Publication type:
- Article
Characteristics and management of the haemophilia‐associated pseudotumours.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 33, doi. 10.1111/hae.13870
- By:
- Publication type:
- Article
Positive emotions despite substantial burden: The alchemy of haemophilia caregiving.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 86, doi. 10.1111/hae.13874
- By:
- Publication type:
- Article
ST‐Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e5, doi. 10.1111/hae.13871
- By:
- Publication type:
- Article
Instructions for Authors.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. 173, doi. 10.1111/hae.13787
- Publication type:
- Article
Patient profile, clinical characteristics and treatment response in acquired haemophilia A: A retrospective analysis of a single‐centre experience over a 3‐year period.
- Published in:
- Haemophilia, 2020, v. 26, n. 1, p. e1, doi. 10.1111/hae.13869
- By:
- Publication type:
- Article